[The syndromes of insulin resistance (type A and B)].
Araki
S
S
Second Department of Internal Medicine, Kobe University School of Medicine.
Kasuga
M
M
D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D011972:Receptor, Insulin / Q000235:genetics*; D013577:Syndrome
D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D007334:Insulin-Like Growth Factor I; D003520:Cyclophosphamide; D011972:Receptor, Insulin